MedTrace Logo

Cash Payment and Counseling During Pregnancy

NCT04572178 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-11-30

No results posted yet for this study

Summary

Smoking during pregnancy has harmful effects on both mother and unborn child. Studies have shown that small rewards can help smokers to quit. In our current study, we ask how such rewards are most effective in supporting smoking cessation in pregnancy.

Conditions

  • Smoking Cessation
  • Pregnancy Related
  • Incentives

Interventions

BEHAVIORAL

Cash payment and brief behavioral counseling

The intervention consists of: (i) in person brief behavioral counseling, (ii) the evaluation of the smoking status using breath carbon monoxide, and (iii) cash payment of 25 Euro if the reading does not exceed a carbon monoxide value "3 ppm" ( ppm = parts per million) on two consecutive measurements per week. The intervention starts at the earliest in pregnancy week 15 and lasts until the delivery. If they relapse, the reward is not paid. However, in the following week they have the opportunity to quit smoking and being rewarded again.

Sponsors & Collaborators

  • Liselotte-Beutel-Foundation

    collaborator UNKNOWN

  • Ministry of Social Affairs, Integration and gender Equality

    collaborator UNKNOWN

  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Sabina Ulbricht, Prof. Dr. · University Medicine Greifswald, Dep. Prevention Research and Social Medicine

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04572178 on ClinicalTrials.gov